• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube

International Alliance of ALS/MND Associations

  • Members' Login
  • Contact
  • Join the Alliance
  • Donate
  • Understanding ALS/MND
    • What is ALS/MND
    • Genetics
    • Diagnosis
    • Glossary
    • Navigating the Community
  • Find a Member Association
  • Support for PALS & CALS
    • Fundamental Rights for People with ALS/MND and Caregivers
    • Research
      • Voice Preservation
      • Open Science
        • Open Label Extension
      • Expanded Access
      • Understanding ALS/MND Research
      • Improving Regulatory Pathways
      • Right to Try
      • US FDA Orphan Drug Designation
      • Unproven (Off-Label) Treatments
    • Advocacy
      • Advocacy Toolkit
      • Emergency Preparedness Toolkit
      • Equitable Access to Therapies
      • Recommendations for Trial Sponsors
    • Clinical Care
      • Genetic Counselling & Testing
      • Mental Health Support
      • Nursing and Symptom Management
      • Nutrition and Swallowing
      • Occupational Therapy and Activities of Daily Living
      • Physiotherapy and Mobility
      • Respiratory Care
      • Speech Therapy and Communication
      • Support for Family & Caregivers
      • Technology
      • Global Clinic Locator
    • Drugs in Development
      • AB Science – Masitinib
      • BrainStorm Cell Therapeutics – NurOwn
      • Clene Nanomedicine – CNM-Au8
      • ILB – Tikomed
      • Kadimastem – AstroRx
      • Mitsubishi Tanabe Pharma America – Oral Edaravone
      • Neuronata-R/Lenzumestrocel
      • NeuroSense – PrimeC
      • Neuvivo – NP001
      • Prilenia Therapeutics – Pridopidine
      • SOD1 Therapies & Trials
      • SPG302
      • T Regulatory Cell Therapies
      • Ulefnersen – Ionis Pharmaceuticals
    • Approved Drugs
      • Nuedexta
      • Radicava/Edaravone
      • Riluzole/Tiglutik
      • Rozebalamin/Methylcobalamin
      • Tofersen/Qalsody
    • Drugs No Longer in Development
      • Amylyx – AMX0035
      • Collaborative Medicinal Development – CuATSM
      • Cytokinetics – Reldesemtiv
      • Orphazyme – Arimoclomol
      • TUDCA Trial
  • Support for Health Professionals
    • Breaking the News in ALS/MND
  • Events/Programs
    • Calendar of Events/Programs
    • Global Day Calendar
    • Alliance Meeting
    • Allied Professionals Forum
    • “Day in the Life Of” Suite
    • Alliance Webinars
    • ALS/MND Connect
    • March of Faces
    • Patient Fellows Program
    • Alliance Fellows
    • SEED Grant Program
    • International Symposium
  • About
    • Who We Are
    • ALS/MND Health Literacy Map
    • Board of Trustees
    • Councils, Forums & Committees
      • Scientific Advisory Council
      • PALS and CALS Advisory Council
      • Advocacy and Public Policy Forum
      • Research Directors Forum
      • Governance Committee
      • Finance Committee
    • Staff
    • History
    • Archives
      • Newsletters
      • Meetings
    • Awards
      • Forbes Norris Award
      • Humanitarian Award
      • Allied Health Professional Award
      • Student Innovation Award
  • Members
    • Member Registration
    • Forgot Password

Donate

Give today. Help build a world free of ALS/MND.

Everything we do is grounded in a simple belief: where you live should not determine the care, support, or dignity you receive after an ALS/MND diagnosis.

Together with nearly 80 member organizations worldwide, we strengthen care, coordinate research, and advocate for equitable access to therapies and support.

Your one-time or monthly donation helps drive this global effort, ensuring no one is left behind.

Thank you for your support. 

  • All fields are required except Address Line 2
  • This field is for validation purposes and should be left unchanged.

Primary Sidebar

  • Danny Reviers, Belgium

    Danny Reviers, Belgium

  • Torben Mikkelsen, Denmark

    Torben Mikkelsen, Denmark

  • Michel Perrozzo, France

    Michel Perrozzo, France

  • Kirsty Gerlach, New Zealand

    Kirsty Gerlach, New Zealand

  • Yessenia Hernandez Mendoza, Mexico

    Yessenia Hernandez Mendoza, Mexico

  • Marco Antonio Alvarez Mercado, Mexico

    Marco Antonio Alvarez Mercado, Mexico

  • Andres Estevez Guersznik, Ireland

    Andres Estevez Guersznik, Ireland

  • Aida Trzmiel de Guterman, Argentina

    Aida Trzmiel de Guterman, Argentina

  • Mona H. Bahus and Camilla Knoff Glomstad, Norway

    Mona H. Bahus and Camilla Knoff Glomstad, Norway

  • Karl Hughes, Ireland

    Karl Hughes, Ireland

  • Chen Yin Xue, Taiwan

    Chen Yin Xue, Taiwan

  • Luis Antonio Pimenta Lima, Brazil

    Luis Antonio Pimenta Lima, Brazil

  • Den Haag, Netherlands

    Den Haag, Netherlands

  • Dorette Lüdi, Switzerland

    Dorette Lüdi, Switzerland

  • Timmy, Belgium

    Timmy, Belgium

  • Chen Chun-Chin, Malaysia

    Chen Chun-Chin, Malaysia

  • Fernando Ocampo Cardona, Colombia

    Fernando Ocampo Cardona, Colombia

  • Sébastien Batiot, France

    Sébastien Batiot, France

  • Susan Keldani, USA

    Susan Keldani, USA

  • Liam Dwyer, England

    Liam Dwyer, England

  • John Russo, USA

    John Russo, USA
    final3878

  • Christian Bär, Germany

    Christian Bär, Germany

  • Ann Nicol, USA

    Ann Nicol, USA

  • Philip Brindle, England

    Philip Brindle, England

  • Angelique van der Lit-van Veldhuizen, Netherlands

    Angelique van der Lit-van Veldhuizen, Netherlands

  • Andrietta, Italy

    Andrietta, Italy
    Andrietta

  • Yannick Richard, Canada

    Yannick Richard, Canada
    yannickrichard

  • Anna Barrow, UK

    Anna Barrow, UK

  • Mikey Stone, ALS

    Mikey Stone, ALS

  • Greg Heydet, USA

    Greg Heydet, USA

  • Josée Kolijn-de Man, Netherlands

    Josée Kolijn-de Man, Netherlands

  • Jose Rivero Muñoz, Mexico

    Jose Rivero Muñoz, Mexico

  • Joyce Rusinak, USA

    Joyce Rusinak, USA

  • Cath Muir, UK

    Cath Muir, UK
    Cath

  • Leon Ryba, Argentina

    Leon Ryba, Argentina

  • Federica Mastrosimone, Italy

    Federica Mastrosimone, Italy

  • Jay Epstein, USA

    Jay Epstein, USA

  • Liam Dwyer, England

    Liam Dwyer, England

  • PALS and CALS, Singapore

    PALS and CALS, Singapore

  • Paul Launer, USA

    Paul Launer, USA

  • Chirag Walia, India

    Chirag Walia, India
    ChiragWalia

  • Chun Ju Xiao, China

    Chun Ju Xiao, China

  • Erwin Coppejans, Belgium

    Erwin Coppejans, Belgium

  • Margreth Burger-Saile, Switzerland

    Margreth Burger-Saile, Switzerland

  • Fabio Carvalho, Brazil

    Fabio Carvalho, Brazil

  • Patrick Shuma, Kenya

    Patrick Shuma, Kenya

  • Osiel Mendoza, USA

    Osiel Mendoza, USA

  • Kirsten Harley, Australia

    Kirsten Harley, Australia

  • Robbie Caliste, UK

    Robbie Caliste, UK

  • Elisabeth Zahnd, Switzerland

    Elisabeth Zahnd, Switzerland

Learn more about the March of Faces

Footer

Stay connected to the global ALS/MND community.

Subscribe to receive our newsletter and updates on how to get involved across the Alliance network.

 
This field is for validation purposes and should be left unchanged.
  • Email
  • Facebook
  • LinkedIn
  • Twitter
  • YouTube
Return to top of page

Contact | Disclaimer | Privacy Notice & Cookies | Sitemap

Copyright © 2026 The International Alliance of ALS/MND Associations. All rights reserved.


Registered in England: Charity Number 1079504 · Site built by graphics.coop · Powered by WordPress · Members' login